Stage III Non-small Cell Lung Cancer Clinical Trials

39 clinical trials for Stage III Non-small Cell Lung Cancer across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer — RECRUITING · PHASE1
• PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC — RECRUITING · PHASE2
• PALACE: Cemiplimab Trial According to ctDNA Levels — RECRUITING · PHASE2
• The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients — RECRUITING · NA
• Study of Tislelizumab for Locally Advanced Non-Small Cell Lung Cancer Following Neoadjuvant Chemotherapy Plus Tislelizumab ± Bevacizumab and Definitive Concurrent Chemoradiation Therapy — RECRUITING · PHASE2
• Heterogeneously Hypofractionated Radiotherapy for Locally Advanced NSCLC — RECRUITING · NA
• Clinical trial looking at different radiotherapy treatment schedules following chemotherapy for patients with non-small cell lung cancer — ACTIVE_NOT_RECRUITING
• In Vivo Fluorescence Molecular Bronchoscopy of Durvalumab-680LT in Patients With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) After Chemoradiotherapy — NOT_YET_RECRUITING · PHASE2
• IFCT-2501 IDEATION ctDNA-guIDEd consolidATION immunotherapy after chemoradiotherapy in patients with stage III non-small cell lung cancer — NOT_YET_RECRUITING · PHASE2
• Durvalumab and Consolidation SBRT Following Chemoradiation for Locally Advanced Stage III Non-Small Cell Lung — COMPLETED · PHASE2
• Daily Adaptive Radiation Therapy: An Individualized Approach for Stage III Lung Cancer — WITHDRAWN · NA
• Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475 — COMPLETED · PHASE2
• Chemoradiation Followed by Durvalumab in Poor Risk and/or Elderly Patients With Stage III NSCLC — TERMINATED · PHASE2
• Study of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal Cancer — TERMINATED · PHASE1
• Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer — COMPLETED · NA
• ChemoRadiotherapy with Or Without surgery followed by consolidation Durvalumab (CROWD): a phase IV feasibility trial — TERMINATED · PHASE4
• Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC — COMPLETED · PHASE2
• Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy — OTHER · PHASE2
• Vaccine Therapy in Treating Patients With Colon, Pancreatic, or Lung Cancer — COMPLETED · PHASE1
• Chemoradiation Plus Durvalumab Followed by Surgery Followed by Adjuvant Durvalumab in Patients With Surgically Resectable Stage III (N2) Non-Small Cell Lung Cancer — TERMINATED · PHASE2
• Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer: A Randomised Controlled, Open-label, Phase 2 Trial — NOT_YET_RECRUITING · PHASE2
• Omitting Clinical Target Volume of Unresectable Stage III Non-small-cell Lung Cancer. — COMPLETED
• A Study of TQB2450 in Subjects With Stage III Non-Small Cell Lung Cancer(NSCLC) — OTHER · PHASE3
• Neoadjuvant LDRT Combined With Durvalumab in Potentially Resectable Stage III NSCLC — OTHER · PHASE1
• Treatment of Patients With Stage III Non-small Cell Lung Cancer in Russia" — OTHER
• Construction of CT Radiomics Model for Predicting the Efficacy of Immunotherapy in Patients With Stage III NSCLC — OTHER
• Chemoradiotherapy in Stage III Non-small Cell Lung Cancer (NSCLC) — COMPLETED · PHASE2
• Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery — OTHER · PHASE2
• Real-world Treatment Patterns and Clinical Outcomes in EGFR-mutant Unresectable Locally Advanced NSCLC — OTHER
• A Study of Neoadjuvant Chemotherapy Plus Anlotinib in Stage III(N2) Non-small-cell Lung Cancer — OTHER · PHASE2
• Image-Guided Functional Lung Avoidance Thoracic Radiotherapy for Lung Cancer: A Single-Blind Randomized Trial — OTHER · NA
• Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC — COMPLETED · PHASE1
• Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy Regimens — COMPLETED · PHASE2
• Radiotherapy Dose Complement in the Treatment of Hypoxic Lesions Patients With Stage III Non-small-cell Lung Cancer — OTHER · PHASE2
• Individualized Dose Prescription in Advanced Stage Lung Cancer Patients Using Modern (Chemo)Radiotherapy — TERMINATED · PHASE2
• Prophylactic Cranial Irradiation (PCI) vs Observation in Stage III NSCLC — COMPLETED · PHASE3
• MRI Optimization Study in Stage III NSCLC — OTHER
• Consolidation Chemotherapy/Concurrent Chemo-radiotherapy for Inoperable Stage III Non-small Cell Lung Cancer (NSCLC) — WITHDRAWN · PHASE2
• Hypofractionated Intensity Modulated Chemoradiotherapy to Treat Locally Advanced Non-Small Cell Lung Cancer — OTHER · PHASE2

Refine this search